[Federal Register Volume 72, Number 221 (Friday, November 16, 2007)]
[Notices]
[Page 64675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-22463]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 26, 2007, and published in the Federal 
Register on July 5, 2007, (72 FR 36728), Austin Pharma LLC, 811 Paloma 
Drive, Suite A, Round Rock, Texas 78664, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Alphamethadol (9605).......................  I
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Levo-alphacetylmethadol (9648).............  II
Alfentanil (9737)..........................  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    In reference to drug code 7360 (Marihuana), the company plans to 
bulk manufacture cannabidiol as a synthetic intermediate. This 
controlled substance will be further synthesized to bulk manufacture a 
synthetic THC (7370). No other activity for this drug code is 
authorized for this registration.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Austin Pharma LLC to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Austin Pharma LLC to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-22463 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P